Search
Items tagged with: Neuropharmacology
Researchers have developed and validated an experimental compound, FLAV-27, capable of reversing #cognitive decline in Alzheimer's disease by reprogramming the neuronal epigenome to correct altered gene expression rather than merely clearing amyloid plaques.
#Neuropharmacology #Epigenetics #Neuroscience #sflorg
sflorg.com/2026/03/pharm031426…
#Neuropharmacology #Epigenetics #Neuroscience #sflorg
sflorg.com/2026/03/pharm031426…
Researchers design a pioneering drug capable of reversing cognitive decline in Alzheimer’s disease in animal models
This opens the door to a new category of therapies: epigenetic disease-modifying treatments, which could complement or even replace current strategieswww.sflorg.com